Evaluated: David B. Kaminsky, M.D., USCAP, August 25, 2016
Original release date: August 25, 2016
Access to this course expires on: May 13, 2019
This lecture on molecular pathology of melanocytic tumors provides an update to the rapidly evolving molecular landscape of melanoma.It will discuss how discoveries have increased our understanding of the diverse pathogenesis of melanoma, how these molecular abnormalities can impact treatment, and how they can be used diagnostically.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
Members: $38.00 Add To Cart To Get Your Discount - Not A Member? Click Here
$38.00 - $52.00